LAT and central nervous system cancer: Their uptake is facilitated by large neutral amino acid transporters of the L‐type (LAT) in gliomas and brain metastases (i.e., subtypes LAT1 and LAT2), which are regularly overexpressed in both brain tumor types [9, 20–23].